RYVYL Reports Q1 2024 Results
14 mai 2024 16h05 HE
|
RYVYL Inc.
- Q1 2024 Revenue Increases 49%, Reflecting 185% RYVYL EU Revenue Growth, from Q1 2023 - - Company Management to Host Conference Call at 4:30 pm E.T. on Tuesday, May 14, 2024 - SAN DIEGO, CA, May ...
Parks! America, Inc. to Report Second Quarter Fiscal 2024 Financial Results on May 14, 2024
09 mai 2024 09h00 HE
|
Parks! America, Inc.
Management to host conference call at 4:30 PM ET PINE MOUNTAIN, Georgia, May 09, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA), a leading operator of regional safari parks in the...
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
30 avr. 2024 16h15 HE
|
BioRestorative Therapies, Inc
- Company to provide update on exciting new commercial agreement, as well as Phase 2 clinical trial in Spine and preclinical development program in Obesity - MELVILLE, N.Y., April 30, 2024 (GLOBE...
Parks! America, Inc. to Report First Quarter Fiscal 2024 Financial Results on February 13, 2024
12 févr. 2024 17h45 HE
|
Parks! America, Inc.
Management to host conference call at 4:30 PM ET PINE MOUNTAIN, Georgia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA), a leading operator of regional safari parks in the...
Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones
04 avr. 2023 07h00 HE
|
Oculis SA
ZUG, Switzerland and BOSTON, April 04, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care,...
Processa Pharmaceuticals to Host Conference Call to Discuss Its Second Quarter 2022 Results and Provide 2nd Half Clinical Pipeline Update on August 11, 2022, at 4:30 p.m. EST
05 août 2022 15h00 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of...
Ballantyne Strong to Announce 2021 Fourth-Quarter Financial Results and Host Conference Call on March 24, 2022
17 mars 2022 08h00 HE
|
Ballantyne Strong, Inc.
Charlotte, NC, March 17, 2022 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”) today announced that the Company will issue its 2021 fourth-quarter financial results...
Ballantyne Strong to Announce 2020 First-Quarter Financial Results and Host Conference Call on May 12, 2020
29 avr. 2020 17h28 HE
|
Ballantyne Strong, Inc.
Charlotte, NC, April 29, 2020 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”), a holding company with diverse business activities focused on serving the...
Ballantyne Strong to Announce Second Quarter 2019 Financial Results and Host Conference Call on August 14, 2019
07 août 2019 20h01 HE
|
Ballantyne Strong, Inc.
Omaha, NE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”), a holding company with diverse business activities focused on serving the cinema, retail,...
Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Operational and Financial Results on August 8, 2019
01 août 2019 08h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
- Company to host conference call and webcast on Thursday, August 8 at 8:30 a.m. ET - Norwood, MA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus”...